$VREX

Maheshwari Shubham sold $2.4M of VREX

Maheshwari Shubham (Chief Financial Officer) sold 130,000 shares of Varex Imaging Corp (VREX) at $18.46 ($2.40M total) on 2026-09-11.

Original reporting
SEC EDGAR · Maheshwari Shubham
Published Sep 15, 2026, 9:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:49 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VREX
Bearish
medium confidence
Mentioned
$VREX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VREXBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which some investors view as a bearish signal.

02

Market read

First‑time disclosure of a sizable insider sale; may influence short‑term trading sentiment.

03

What to watch

No 10b5‑1 plan was used, suggesting the sale was discretionary rather than pre‑scheduled.

Relevance 6/10Novelty 6/10Timing: filing date 2026-09-15

Background

Form 4 filings disclose insider transactions; CFO sales are monitored for potential red flags.

Company-level read

Ticker impact

$VREXBearishMedium confidence
Context

CFO Maheshwari Shubham sold 130,000 shares for $2.4M in a Form 4 filing, reducing his stake to 139,972 shares.

Expected impact

Possible modest dip in VREX price over the next few days.

Evidence & confidence

The sale size ($2.4M) is material for a mid‑cap company and is the first public disclosure of the transaction.

Market effects

May raise concerns for the medical imaging equipment sector if other insiders follow suit.

Limited to U.S. markets where VREX trades.

Minimal global impact; primarily a company‑specific signal.

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook; price may remain stable.

Key entities

  • Maheshwari Shubham

    Chief Financial Officer of Varex Imaging Corp.

  • Varex Imaging Corp

    Medical imaging equipment manufacturer (ticker VREX).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDYHighAI 9/10

Los Angeles Business Journal

Teledyne Technologies (TDY) agreed to acquire Varex Imaging (VREX) for $1.1B, or $18.90 per share in cash. The deal is expected to close in 2027. Varex's X-ray imaging tech complements Teledyne's portfolio, according to Varex's CEO. Teledyne has previously acquired firms in the healthcare sector, including Dalsa Corp. and DD-Scientific.

$TDYMedAI 9/10

Why Is Teledyne Technologies (TDY) Paying a 52% Premium for Varex (VREX)?

Teledyne Technologies (NYSE:TDY) agreed to acquire Varex Imaging (NASDAQ:VREX) for $18.90 per share in cash, a 52% premium to Varex’s unaffected close. The deal values Varex at about $1.1 billion including equity awards and net debt. Varex jumped 48.5% to $18.42 on Aug. 10; TDY fell slightly. Teledyne cited synergies but did not quantify EPS accretion.

$TDYMedAI 9/10

Teledyne Technologies to Acquire Varex Imaging

Teledyne Technologies agreed to acquire all outstanding shares of Varex Imaging under a definitive deal approved unanimously by both boards. Varex makes X-ray sources and digital detectors plus imaging software for medical and industrial inspection. The deal is expected to close in early 2027, pending regulatory and Varex stockholder approval.